Business Context and Reporting Period
This Form 8-K is a current report filed by Trxade Group, Inc. (trading symbol: MEDS) on March 30, 2020. The filing serves to announce the issuance of a press release regarding the Company's financial results for the twelve months ended December 31, 2019. The registrant is incorporated in Delaware and is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the body of this Form 8-K.
Material Changes
No material changes or comparative financial data are detailed in the text of this filing. The document solely acts as a conduit to the press release containing the results for the period ended December 31, 2019.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The referenced press release contains forward-looking statements regarding future financial performance, events, and trends. These are subject to known and unknown risks, uncertainties, and assumptions.
- Risk Factors: The filing explicitly warns that actual results may differ materially from projected statements. Risks are detailed in the Company's periodic filings (Form 10-K, Form 10-Q) under sections titled "Forward-Looking Statements," "Risk Factors," and "Management's Discussion and Analysis."
- Update Obligation: The Company states it undertakes no obligation to publicly update or revise forward-looking statements after the date of the filing, except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 30, 2020) for specific financial figures for the year ended December 31, 2019.
- Verify the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Consult the Company's most recent Form 10-K and Form 10-Q filings on the SEC website or the Company's investor relations page for detailed risk factors and management commentary.
- Note that the filing explicitly states the information is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.